Press Releases from Marinomed Biotech AG (2 total)
Marinomed extends the range of Marinosolv applications
o Preclinical studies show promising results with new compounds like mometasone, fluticasone and fluorometholone
o Potential for developments in allergy, asthma, and ophthalmology
o Marinosolv facilitates the combination of…
Marinomed Biotech AG: Clinical validation of the Marinosolv® platform
Marinomed Biotech AG: Budesolv with a strongly decreased dose of the active ingredient compared to the marketed product Rhinocort Aqua shows pronounced efficacy already after…
Go To Page:
